VOC Sensor Array Monitoring for Real-Time Infection Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting surgical infections, particularly in orthopedic and breast surgeries, are time-consuming, invasive, and lack specificity, complicating timely and accurate post-surgical infection management, especially with multi-drug resistant organisms.
Innovation Solution
A device and method for real-time detection and monitoring of pathogens in clinical specimens using a sensor array that analyzes gaseous biosignatures, such as volatile organic compounds, with multi-modal data fusion and machine learning algorithms to provide immediate, non-invasive infection diagnosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional microbiological testing methods are used, then infection diagnosis can be performed, but the process is time-consuming and delays treatment
Solution Approach 1:
The patent replaces traditional mechanical microbiological testing methods with optical detection technology. The system uses optical sensors to detect volatile organic compounds (VOCs) emitted by bacteria, transforming the detection mechanism from cultural growth-based to optical signal-based, thereby achieving rapid real-time detection without time-consuming culture processes
Solution Approach 2:
The patent introduces VOCs (volatile organic compounds) as an intermediary substance that mediates between the pathogen and the detection system. Bacteria emit specific VOCs during metabolism, and the optical detection system detects these VOCs to identify pathogen presence, enabling indirect but rapid detection without direct pathogen culture
2Quantity of substance
If invasive sample collection procedures are used, then sufficient clinical specimens can be obtained, but patient discomfort and procedural complexity increase
Solution Approach 1:
The patent replaces invasive mechanical sampling procedures with non-invasive vapor-phase detection. Instead of requiring large volumes of fluid or tissue samples through invasive collection, the system detects bacterial VOCs that naturally emanate from the specimen, eliminating the need for invasive sample acquisition while still obtaining sufficient diagnostic information
3Loss of information
If traditional diagnostic methods are used, then infection presence can be determined, but pathogen identification and growth monitoring remain insufficient
Solution Approach 1:
The patent segments the detection process into multiple independent optical detection channels, each targeting specific VOCs or metabolic indicators. This segmentation allows simultaneous detection of multiple pathogen characteristics (presence, identity, growth rate) through parallel optical measurements, providing comprehensive information without requiring a single complex monolithic system
Solution Approach 2:
The patent creates a universal detection platform that can identify multiple types of pathogens and monitor their growth dynamics using a single integrated optical detection system. The system universally detects various VOCs and metabolic byproducts, enabling identification of different pathogen species and real-time growth monitoring through one multi-functional device rather than multiple specialized tests
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, accurate, and continuous monitoring of microbial status, reducing the need for invasive procedures and improving patient outcomes by providing immediate feedback on pathogen presence, identity, load, and growth rate.
Implementation Method 1
at least one chemiresistive gas sensor positioned to detect gaseous analytes released from the clinical specimen
Data Source
AI summary
A device and method are disclosed for the real-time monitoring and detection of infectious agents in clinical specimens. The device utilizes a sensor array to detect gaseous biosignatures, such as volatile organic compounds (VOCs), released by metabolically active pathogens. A data processing module with an artificial intelligence (AI) algorithm analyzes multi-sensor data to generate a time-resolved biosignature profile. The algorithm interprets this profile to provide diagnostic outputs, including pathogen presence, identity, an estimation of microbial load (e.g., CFU/mL), and, notably, a determination of the microbial growth rate calculated from the profile's change over time. Embodiments of the device include handheld point-of-care analyzers, integrated ‘smart caps’ for specimen containers, and in-line monitors for surgical drains. The technology enables rapid, data-driven clinical decisions for infection management by providing timely and dynamic assessments of microbial activity.